SHORTCAST: Accurate prediction of vaccine candidates using a novel HLA-peptide-TCR-binding tool: OncopeptVAC™ and their validation by OncoPeptSCRN
During this webcast the speaker will address:
- Challenges in accurate prediction of immunogenic neoantigens
- Benefits of the OncoPeptVAC platform
- Assay for immunogenicity of peptides predicted using OncoPeptVAC using OncoPeptSCRN
- Insights into the discoveries made possible using OncoPeptVAC in combination with OncoPeptSCRN & TCR repertoire assays
- Benefits of TCR repertoire profiling to assay for immunogenicity